Angiogenesis Inhibitors，Ovarian Neoplasms
1 clinical trials · Condition
◉ Watch Angiogenesis Inhibitors，Ovarian Neoplasms
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer (NCT03262545) | Sichuan Cancer Hospital and Research Institute | 2017-08-27 |
Track Angiogenesis Inhibitors，Ovarian Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.